Company Profile

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE3144.8048.6 (+1.57 % )
PREV CLOSE (Rs.) 3096.20
OPEN PRICE (Rs.) 3095.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 21379
TODAY'S LOW / HIGH (Rs.)3027.55 3218.55
52 WK LOW / HIGH (Rs.)2352 3363
NSE3146.80 51.8 (+1.67 % )
PREV CLOSE(Rs.) 3095.00
OPEN PRICE (Rs.) 3085.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 3146.80 (7 )
VOLUME 1173674
TODAY'S LOW / HIGH(Rs.) 3025.10 3218.85
52 WK LOW / HIGH (Rs.)2351.2 3364.95

Board Meetings

Source Date Board Meeting Date Details
26-Dec-2019 27-Jan-2020 Quarterly Results
24-Sep-2019 01-Nov-2019 DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2019 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company will be held on Friday, November 1, 2019, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half-year ended September 30, 2019.
26-Jun-2019 29-Jul-2019 DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2019 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2019.
01-Apr-2019 17-May-2019 Final Dividend & Audited Results
03-Jan-2019 01-Feb-2019 DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2019 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2018. Further, kindly note that the Company''s trading window for dealing in securities by the ''Insiders'' is closed from Monday, January 7, 2019 and ending on Sunday, February 3, 2019 (both days inclusive).
01-Oct-2018 26-Oct-2018 DR.REDDYS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2018 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half-year ended September 30, 2018.
04-Jul-2018 26-Jul-2018 Quarterly Results
11-Apr-2018 22-May-2018 Board Meeting Notice
02-Jan-2018 25-Jan-2018 Intimation of Board Meeting to be held on January 25, 2018.
05-Oct-2017 31-Oct-2017 Quarterly Results